Plain English Summary
Cagrilintide is a GLP-1 receptor agonist that has shown promising results for weight loss in individuals with overweight or obesity when coadministered with semaglutide. It resulted in significant reductions in body weight compared to placebo, particularly in a clinical trial involving over 3400 participants.
What People Use It For
Side Effects & Risks
Common Side Effects
References
- 1https://pubmed.ncbi.nlm.nih.gov/40544433/
- 2https://pubmed.ncbi.nlm.nih.gov/38286487/
- 3https://pubmed.ncbi.nlm.nih.gov/40544432/
- 4https://pubmed.ncbi.nlm.nih.gov/34798060/
- 5https://pubmed.ncbi.nlm.nih.gov/37364590/
- 6https://pubmed.ncbi.nlm.nih.gov/39317404/
- 7https://pubmed.ncbi.nlm.nih.gov/36883831/
- 8https://pubmed.ncbi.nlm.nih.gov/34783910/
Researchers also explore
PYY 3-36 (Peptide YY 3-36)
PYY 3-36 is a peptide hormone that plays a key role in regulating appetite and energy balance. It is a truncated form of peptide YY, primarily secreted by the intestine after feeding, and is involved in satiety, reducing food intake, and potentially impacting insulin sensitivity and gut motility.
AOD-9604
AOD-9604 is a peptide that is being researched for its potential to aid in obesity treatment and tissue regeneration. It activates the IGF-1 signaling pathway and has not been found to affect doping tests related to human growth hormone.
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most effective weight loss medications available. It works by mimicking a natural hormone that regulates appetite and blood sugar, helping people feel full faster and longer.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even stronger weight loss results than semaglutide in clinical trials. It targets two hormone pathways instead of one, making it potentially more effective for both weight loss and blood sugar control.
Researcher Sentiment
No votes yet — be the first
Educational Content Only
This is not medical advice. Always consult a licensed healthcare provider before using any compound. No dosing or sourcing guidance is provided.